a chemotherapy protocol which includes etoposide and mitoxantrone in addition to MACOP-B with half dose of methotrexate and half administration of doxorubicin; used for the treatment of advanced stage aggressive non-Hodgkin's lymphoma; reduces severe mucositis, a major toxic effect of MACOP-B